Research location
Adelaide
Australia
Advertisement
Research activity in Adelaide
AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 154 trials and 161 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Adelaide
154 linked trials · page 1 of 4BIO|STREAM.CSP StudyNCT07393009 · 2026-05-25 · 1 site observation
RECRUITING
A Study of LY3439539 in Participants With Alzheimer's DiseaseNCT07598370 · 2026-05-21 · 1 site observation
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightNCT07369011 · 2026-02-10 · 1 site observation
RECRUITING
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)NCT07222332 · 2026-02-05 · 1 site observation
RECRUITING
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerNCT07288177 · 2026-01-30 · 1 site observation
RECRUITING
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsNCT07222137 · 2026-01-12 · 1 site observation
RECRUITING
Sapu003 in Advanced mTOR-sensitive Solid TumorsNCT07369505 · 2025-12-15 · 1 site observation
RECRUITING
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)NCT07111520 · 2025-09-22 · 1 site observation
RECRUITING
A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid TumorsNCT07147348 · 2025-08-27 · 1 site observation
RECRUITING
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)NCT06757634 · 2025-07-24 · 1 site observation
RECRUITING
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCNCT06855277 · 2025-07-01 · 1 site observation
RECRUITING
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerNCT06827236 · 2025-04-23 · 1 site observation
RECRUITING
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinNCT06677060 · 2025-03-14 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2DNCT06829563 · 2025-01-30 · 1 site observation
RECRUITING
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsNCT06750185 · 2025-01-13 · 1 site observation
RECRUITING
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerNCT06712316 · 2025-01-07 · 2 site observations
RECRUITING
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerNCT06435429 · 2024-08-13 · 1 site observation
RECRUITING
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)NCT06439277 · 2024-06-03 · 1 site observation
RECRUITING
A Study of Sofe-M in Participants With Selected Advanced Solid TumorsNCT06400472 · 2024-05-20 · 1 site observation
RECRUITING
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsNCT06008197 · 2024-01-17 · 1 site observation
RECRUITING
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerNCT05950945 · 2023-12-30 · 1 site observation
RECRUITING
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNCT06119581 · 2023-12-21 · 1 site observation
RECRUITING
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.NCT07630545 · 2023-11-30 · 1 site observation
RECRUITING
Virtual perI-/Menopause Registry of AusTrALiaNCT06487130 · 2023-08-03 · 1 site observation
RECRUITING
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)NCT06923761 · 2023-05-21 · 1 site observation
RECRUITING
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid TumorNCT05523947 · 2022-08-26 · 1 site observation
RECRUITING
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid TumorsNCT05307705 · 2022-05-11 · 1 site observation
RECRUITING
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone DiseaseNCT05136222 · 2021-12-15 · 1 site observation
RECRUITING
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCNCT04686305 · 2021-03-09 · 1 site observation
RECRUITING
A Study of SA030 Injection in Overweight or Obese ParticipantsNCT07479862 · 2026-04-16 · 1 site observation
NOT_YET_RECRUITING
Assessment of Safety, Tolerability and Drug Levels of Exenatide ImplantNCT05670379 · 2024-12-20 · 1 site observation
COMPLETED
BIO|MASTER.CSP StudyNCT06620237 · 2024-10-04 · 1 site observation
ACTIVE_NOT_RECRUITING
MagDI Australia StudyNCT06473831 · 2024-08-13 · 1 site observation
COMPLETED
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)NCT06421935 · 2024-08-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With ChemotherapyNCT06449209 · 2024-08-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's VaccineNCT06831812 · 2024-06-12 · 1 site observation
COMPLETED
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersNCT05891171 · 2023-10-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Single and Multiple Ascending Dose Study of AER-01NCT05862623 · 2023-05-26 · 1 site observation
UNKNOWN
A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive SubjectsNCT06905327 · 2023-03-08 · 1 site observation
COMPLETED
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)NCT05555732 · 2023-01-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)NCT05501886 · 2022-12-08 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityNCT05556512 · 2022-10-11 · 2 site observations
ACTIVE_NOT_RECRUITING
External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)NCT05146973 · 2022-08-30 · 1 site observation
COMPLETED
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung CancerNCT05388669 · 2022-08-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaNCT05251259 · 2022-01-27 · 1 site observation
COMPLETED
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesNCT05081609 · 2022-01-11 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy ParticipantsNCT05053165 · 2022-01-04 · 1 site observation
COMPLETED
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)NCT05036135 · 2021-12-02 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.